Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 4

1(33.3%)

Phase 1

1(33.3%)

3Total

N/A(1)

Phase 4(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07040358Active Not Recruiting

Rapid Abdominal Diagnosis With AI & Radiology

Role: collaborator

NCT05794841Unknown

Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract

Role: collaborator

NCT04915690Unknown

Investigation on the Practice Status of Emergency Stuff

Role: collaborator

NCT03771378Phase 4Unknown

Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)

Role: collaborator

NCT03366324Phase 1Unknown

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Role: collaborator

NCT02299258Not ApplicableCompleted

Gastric Outlet Obstructions Tailored Covered Stents for GOO

Role: lead

All 6 trials loaded